Cargando…

Redefining resectability in pancreatic cancer after neoadjuvant therapy: are we any closer?

Detalles Bibliográficos
Autores principales:	Robertson, Francis P., Pandanaboyana, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944546/ https://www.ncbi.nlm.nih.gov/pubmed/36860247 http://dx.doi.org/10.21037/hbsn-22-638

Ejemplares similares

Prehabilitation in lung cancer resection—are we any closer to the ideal program?
por: Mahendran, Kajan, et al.
Publicado: (2020)

Pathogenesis and biomarkers for necrotizing enterocolitis: Getting any closer?
por: Nguyen, Duc Ninh, et al.
Publicado: (2019)

Neoadjuvant therapy for resectable pancreatic cancers
por: Inoue, Yosuke, et al.
Publicado: (2022)

Cannabis and Psychosis: Are We any Closer to Understanding the Relationship?
por: Hamilton, Ian, et al.
Publicado: (2019)

Therapeutic Neovascularization for Refractory Angina—Are We Any Closer?
por: Alkhunaizi, Fatimah A., et al.
Publicado: (2023)

Recurrence Patterns for Pancreatic Ductal Adenocarcinoma after Upfront Resection Versus Resection Following Neoadjuvant Therapy: A Comprehensive Meta-Analysis
por: Ratnayake, Bathiya, et al.
Publicado: (2020)

Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
por: Kim, Dong Uk
Publicado: (2022)

Schizophrenia pathophysiology: are we any closer to a complete model?
por: Lakhan, Shaheen E, et al.
Publicado: (2009)

Schizophrenia genomics and proteomics: are we any closer to biomarker discovery?
por: Lakhan, Shaheen E, et al.
Publicado: (2009)

Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer?
por: Singh, Meera V., et al.
Publicado: (2017)

β‐cell replacement therapy for type 1 diabetes: closer and closer
por: Jones, Peter M., et al.
Publicado: (2022)

Commentary: Anatomic resection after neoadjuvant TKI therapy—To be forewarned
por: Chang, Andrew C.
Publicado: (2021)

Viral markers for HIV cure trials: are we getting any closer?
por: De Spiegelaere, Ward
Publicado: (2016)

Do we need sequential local therapy following neoadjuvant chemotherapy for locally advanced pancreatic cancer?
por: Kleeff, Jörg, et al.
Publicado: (2019)

Are we closer to personalized therapy in juvenile idiopathic arthritis?
por: Smolewska, Elżbieta
Publicado: (2016)

Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
por: Lan, Xiaoyang, et al.
Publicado: (2023)

Are we closer to providing better guidance for prescribing metformin and exercise to patients?
por: Malin, Steven K., et al.
Publicado: (2022)

Crystalloid or colloid for resuscitation. Are we any the wiser?
por: Webb, Andrew R
Publicado: (1999)

Resurgence of the COVID-19 cases in Northern Afghanistan: Are we closer to fifth wave?
por: Asady, Abdullah, et al.
Publicado: (2022)

Neoadjuvant therapy in localized non-small cell lung cancer: can we do better than chemotherapy?
por: Chau, Brittney, et al.
Publicado: (2019)

Need for redefining needs
por: Asadi-Lari, Mohsen, et al.
Publicado: (2003)

Neoadjuvant therapy for resectable pancreatic cancer
por: Rahman, Sheikh Hasibur, et al.
Publicado: (2017)

Edging closer to successful gene therapy for Wilson disease
por: Sandahl, Thomas Damgaard, et al.
Publicado: (2022)

Are we closer to having drugs to treat muscle wasting disease?
por: Morley, John E., et al.
Publicado: (2014)

Why We Should Take a Closer Look at Gestures
por: Walther, Sebastian, et al.
Publicado: (2016)

Neoadjuvant immunotherapy with resectable non-small cell lung cancer: recent advances and future challenges
por: Ren, Sijia, et al.
Publicado: (2020)

Guidelines on cholangioscopy for indeterminate biliary strictures: one step closer to consensus
por: Ayoub, Fares, et al.
Publicado: (2023)

Swine flu-have we learnt any lesson from the past?
por: Yadav, Sankalp, et al.
Publicado: (2015)

Neoadjuvant treatment of rectal cancer: where are we now?
por: Kalyan, Aparna, et al.
Publicado: (2016)

Are We Getting Closer to Risk Stratification in Left Ventricular Noncompaction Cardiomyopathy?
por: Jefferies, John L.
Publicado: (2018)

Pain mechanisms in sickle cell disease. Are we closer to a breakthrough?
por: Conran, Nicola
Publicado: (2022)

Multiculturalism and interculturalism: redefining nationhood and solidarity
por: Kastoryano, Riva
Publicado: (2018)

Podocyturia: Is there any clinical utility?
por: Yadav, I., et al.
Publicado: (2011)

Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?
por: Jani, Meghna, et al.
Publicado: (2019)

2D Strain Analysis in Myocarditis—Can We Be Any Closer to Diagnose the Acute Phase of the Disease?
por: Supeł, Karolina, et al.
Publicado: (2023)

Redefining radiology senior residency – Can we provide an alternative to “The Consultant Job”
por: Mohan, Chander
Publicado: (2017)

Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?
por: O'Neill, Robert S, et al.
Publicado: (2021)

Neoadjuvant targeted therapy for advanced renal cell carcinoma: Where do we stand?
por: Grivas, Nikolaos K.
Publicado: (2019)

Immunomodulation as Therapy for Fungal Infection: Are We Closer?
por: Sam, Qi Hui, et al.
Publicado: (2018)

Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
por: Mikulic, Danko, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f01et8kvo9li1lih1p935fs619